Search

Results from a clinical trial indicate that an experimental CAR therapy for mesothelioma is safe.

… Sunday, March 31, 2019 Summary Scientists at Memorial Sloan Kettering are investigating ways to develop effective CAR T cell therapies for solid tumors. Results from a clinical trial in people with mesothelioma indicate that an experimental CAR therapy is safe and may provide benefit to patients, especially

Collaboration leads to a new digital pathology tool that allows some doctors to diagnose patient tumors from home.

… Monday, September 21, 2020 Summary MSK’s Pathology Department has developed new digital technologies to keep its workers safe without having to compromise patient care — allowing some of its doctors to work from home. During the COVID-19 pandemic, Memorial Sloan Kettering doctors and nurses have been

Learn about larotrectinib, the first cancer drug to be FDA approved for adult and pediatric patients at the same time.

… Monday, November 26, 2018 Summary Larotrectinib is the first cancer drug to be FDA approved based on its effect on a specific mutation in a tumor. The US Food and Drug Administration has approved the drug larotrectinib (Vitrakvi®; LOXO-101) for cancers caused by a genetic mutation called a TRK fusion

This study demonstrates how clonal hematopoiesis (CH)–derived mutations could lead to erroneous reporting and treatment recommendations when tumor-only sequencing is employed. If data about the blood are not part of test results, mutations present in the blood may be misread as mutations in the tumor, which can potentially affect the therapies patients receive. Data presented at the annual meeting of the American Society of Clinical Oncology by Ahmet Zehir, PhD, Director of Clinical Bioinformatics at Memorial Sloan Kettering Cancer Center (MSK) was simultaneously published in JAMA Oncology on June 5.

… Tuesday, June 5, 2018 Bottom Line: This study demonstrates how clonal hematopoiesis (CH)–derived mutations could lead to erroneous reporting and treatment recommendations when tumor-only sequencing is employed. If data about the blood are not part of test results, mutations present in the blood may be

Learn the difference between CT Scan and MRI and how doctors use these imaging techniques to diagnose and stage cancer.

… Wednesday, June 4, 2025 Getting the right diagnosis often starts with the right imaging test, but how do you know which one is right for you? If your doctor has recommended a  CT scan  or an  MRI , you might be wondering what the difference is — and why one might be chosen over the other. Both tests

As part of Memorial Sloan Kettering’s 33rd annual academic convocation on May 11, the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences awarded PhDs to four graduates.

… Friday, May 18, 2012 Summary As part of Memorial Sloan Kettering’s 33rd annual academic convocation on May 11, the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences awarded PhDs to four graduates. Congratulations to the first graduating class of the Louis V. Gerstner, Jr. Graduate School

In honor of his extraordinary contributions to improving the diagnosis and treatment of childhood cancer, Richard O’Reilly, Chairman of the Department of Pediatrics and Director of the Bone Marrow Transplantation Program at MSK, will receive the first Society of Memorial Sloan Kettering Prize.

… Monday, May 2, 2016 In honor of his extraordinary contributions to improving the diagnosis and treatment of childhood cancer, Richard O’Reilly, Chairman of the Department of Pediatrics and Director of the Bone Marrow Transplantation Program at MSK, will receive the first Society of Memorial Sloan Kettering

MSK researchers shared their latest research developments at the 2021 meeting of the American Association for Cancer Research.

… Wednesday, April 14, 2021 Three Memorial Sloan Kettering experts shared important research findings in plenary talks during Week 1 of the American Association for Cancer Research’s (AACR) virtual Annual Meeting 2021, held from April 10 to 15. Two presentations shed light on how genetic mutations lead

The Prospective Registry Of Multi-Plex Testing (PROMPT) - a new online, volunteer registry for individuals who have been tested for inherited mutations in cancer-causing genes - will provide data vital to improving our understanding of newly discovered, cancer-associated genes and allow current and future generations to better interpret and benefit from knowledge of their genomes.

… Tuesday, September 23, 2014 A newly formed consortium including experts from academic medical centers and commercial genetics laboratories across the country has established the Prospective Registry Of Multi-Plex Testing (PROMPT), an online registry for individuals and families who have undergone testing

Learn how MSK is joining forces with the City of New York to expand access to the COVID-19 vaccine.

… Friday, April 9, 2021 Christy Manso/staff, MSK Staff/vaccinators, Christy in the center Memorial Sloan Kettering Community Programs manager Christy Manso addresses MSK vaccinators. Anika Navaroli/non-staff Resident Anika Navaroli snaps a selfie when it’s her turn to get the vaccine. Claudia Derico/staff